@Flaviker NMRD probably more reasonably priced today or headed back to $1.70 if it appears their schedule might be slipping without at least the proper PR of clinical trial start/success and CE submission
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.